PubRank
Search
About
Roxana Dronca
Author PubWeight™ 8.02
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial.
Lancet
2014
8.63